Ki67 is a marker of cell proliferation and the percent of positive Ki67 cells is slightly decreased in the PDCOs compared to the patient tumor (Figure 3B,C), highlighting an advantage of PDCOs over current GEP-NET cell lines, which typically exhibit Ki67 percentages of 20–90% [13]. The gene discussed is MKI67; the disease is neoplasm.